Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

VivaBioCell

VivaBioCell
2005 FOUNDED
M&A STATUS
1-10 EMPLOYEES
M&A LATEST DEAL TYPE
Description

Provider of next-generation cell and tissue engineering therapies designed to regenerate and repair damaged tissues and organs. The company's cell and tissue engineering therapies can be used to develop immune cells utilized in the treatment of cancer such as natural killer cells enabling its clients to provide safe, efficacious, standardized and affordable medical treatments.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Parent Company
VBC Holdings
Primary Office
  • Via del Cotonificio, 127
  • 33100 Udine
  • Italy

+39 0432 000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore VivaBioCell’s full profile, request a free trial.

VivaBioCell Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 22-Jun-2015 Completed Generating Revenue
1. Early Stage VC 01-Jan-2010 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

VivaBioCell Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Friulia Veneto Sviluppo Venture Capital Minority 000 0000 000000 0

VivaBioCell Executive Team (1)

Name Title Board
Seat
Contact
Info
Francesco Curcio Chief Scientific Officer, President & Founder